By Erin Coe ( July 8, 2009, 12:00 AM EDT) -- Adding to several bills seeking a regulatory pathway for approval of follow-on versions of biologic drugs, Sen. Edward Kennedy, D-Mass., has reportedly put in his own proposal that would allow drugmakers to secure up to 13.5 years of protection on brand-name biologic drugs before a follow-on version could enter the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.